Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.93
-$1.99-10.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.15B | 1.10B | 1.06B | 1.06B | 1.04B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.15B | 1.10B | 1.06B | 1.06B | 1.04B |
| Cost of Revenue | 452.11M | 437.37M | 425.90M | 424.28M | 419.65M |
| Gross Profit | 697.66M | 664.74M | 636.94M | 631.29M | 621.37M |
| SG&A Expenses | 314.28M | 306.22M | 300.56M | 294.38M | 286.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 894.98M | 867.82M | 847.36M | 836.89M | 820.89M |
| Operating Income | 254.79M | 234.28M | 215.48M | 218.68M | 220.13M |
| Income Before Tax | 183.38M | 162.82M | 143.85M | 182.00M | 217.85M |
| Income Tax Expenses | 74.82M | 68.63M | 62.83M | 60.12M | 56.96M |
| Earnings from Continuing Operations | 108.57 | 94.19 | 81.02 | 121.88 | 160.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 108.57M | 94.19M | 81.02M | 121.88M | 160.89M |
| EBIT | 254.79M | 234.28M | 215.48M | 218.68M | 220.13M |
| EBITDA | 317.57M | 293.30M | 271.24M | 271.33M | 269.43M |
| EPS Basic | 0.19 | 0.16 | 0.14 | 0.21 | 0.28 |
| Normalized Basic EPS | 0.26 | 0.24 | 0.22 | 0.23 | 0.23 |
| EPS Diluted | 0.18 | 0.16 | 0.14 | 0.21 | 0.28 |
| Normalized Diluted EPS | 0.26 | 0.24 | 0.22 | 0.23 | 0.23 |
| Average Basic Shares Outstanding | 2.34B | 2.33B | 2.33B | 2.32B | 2.32B |
| Average Diluted Shares Outstanding | 2.35B | 2.35B | 2.34B | 2.34B | 2.33B |
| Dividend Per Share | 0.26 | 0.25 | 0.25 | 0.25 | 0.25 |
| Payout Ratio | 69.51% | 78.34% | 89.85% | 63.19% | 50.13% |
